Device Trial Radar · NCT04580160
Venous Stent for the Iliofemoral Vein Investigational Clinical Trial Using the DUO Venous Stent System
Last checked: Nov 20, 2026Latest source record: May 15, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
162
Actual
Start
Nov 30, 2020
Primary completion
Dec 3, 2022
Study completion Apr 15, 2025
Sponsor
- Lead sponsor
- Vesper Medical, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 8, 2020
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a prospective, multi-center, single-arm, non-blinded clinical trial designed to investigate the safety and efficacy of the Vesper DUO Venous Stent System as compared to a pre-defined performance goal (PG) established from published, peer reviewed scientific literature related to stenting of iliofemoral venous outflow obstructions.
Conditions
- May-Thurner Syndrome
- Deep Vein Thrombosis
- Chronic Venous Insufficiency
Interventions
Duo Venous Stent SystemDevice
Subjects with nonmalignant iliofemoral venous outflow obstruction presenting with nonthrombotic (NT), acute thrombotic (AT) or chronic postthrombotic (CPT) disease pathogenesis will be selected for study participation.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety - Number of Participants Free From Major Adverse Events (MAEs) at 30 DaysTime frame: 30 days
- Efficacy - Number of Participants With Primary Patency of Stented Segment at 12 MonthsTime frame: 12 months
Locations
30 sites in 2 countries. Site status is shown where the registry gives one.
St. Joseph Hospital
Orange, California
Stanford University
Palo Alto, California
The Vascular Experts
Darien, Connecticut
27 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.